Immune Thrombocytopenic Purpura in Patients with COVID-19
KeywordsCOVID-19, SARS-CoV-2, thrombocytopenia, intravenous immunoglobulins
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.
Issue: Vol 7 No 7 (view)